McGill University really is the place for higher learning.

The school was recently awarded a licence from Health Canada to produce cannabis for medical purposes as part of its collaboration with RavenQuest BioMed Inc. The licence allows research to continue into cultivar recognition, yield maximization and other methods of improving production and sustainability of the plant.

“Throughout our partnership with McGill, research has thus far uncovered several key beneficial microbes which have shown significant potential to improve yield and disease resistance,” said George Robinson, CEO of RavenQuest in a press release. “The Health Canada license will allow RavenQuest and McGill to confirm our findings by applying the microbes directly to the cannabis plant.”

Robinson said the company’s goal is to ensure large cannabis producers have the tools to grow the type of consistent crops that make it easier to conduct medical trials. “With the granting of this license, the research we are conducting with our partners at McGill moves us even closer toward that end,” he said.

RavenQuest also entered into a joint agreement earlier this month to produce THC and CBD teas with the Not-So-Gentle Tea Company.

“Our teas will provide a perfect solution for consumers wishing to access cannabis-infused drinks in a discreet, accessible fashion which can be stocked easily by any store, small or large,” Robinson said.